Predilife S.A.
EPA:ALPRE.PA
3.8 (EUR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Predilife S.A. |
Symbool | ALPRE.PA |
Munteenheid | EUR |
Prijs | 3.8 |
Beurswaarde | 14,122,776 |
Dividendpercentage | 0% |
52-weken bereik | 3.32 - 24 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Stephane Ragusa |
Website | https://www.predilife.com |
An error occurred while fetching data.
Over Predilife S.A.
Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)